Independent Director Ameetkumar Desai completes tenure; decides not to seek second term
Independent Director Mr. Ameetkumar Desai (DIN: 00007116) has informed the company he will not seek re-appointment for a second consecutive term.
By ScoutQuest · · 1 min read
- Director DIN
- 00007116
- Tenure Ends
- 27 October 2026
- Reason for Change
- Completion of tenure
What the update says
The company has informed the exchanges that Mr. Ameetkumar Desai (DIN: 00007116), an Independent Director, has decided not to seek re-appointment for a second consecutive term as an Independent Director upon completion of his current first tenure on 27 October 2026.
Consequently, with effect from the close of business hours on 27 October 2026, he ceases to be an Independent Director of the company.
The stated reason for the change is completion of tenure. The company also placed on record its appreciation for the valuable contribution and support provided by him during his association with the company.
What this means in simple terms
- An independent director is a board member who is not part of the company's management and is expected to bring an outside, impartial view to board decisions.
- Independent directors are appointed for a fixed term. At the end of that term, continuing on the board requires a fresh appointment for a second term.
- Here, the director himself decided not to seek that second term. His exit is therefore the scheduled end of his term, not a resignation or a removal.
- The change takes effect from the close of business hours on 27 October 2026.
How to read it
The update is a routine disclosure of a board change. The word used for the reason is completion of tenure, and the update also notes the director's own decision not to seek re-appointment. The company has recorded its appreciation for his contribution.
There is no financial figure, no monetary transaction and no share-related action in this disclosure. The impact on investors is limited to the composition of the board, since an independent director's seat falls vacant on that date.
Also from Hester Biosciences
Hester Biosciences schedules Q2 & H1 FY27 earnings conference call on 5 November 2026 at 2:00 p.m. IST
28 Oct 2026
Board meeting on 5 November 2026 to consider unaudited Q2 and H1 results
27 Oct 2026
Board approves up to INR 10.50 million capital contribution for 26% of Slyce Agri World LLP
6 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.